| Year |
Citation |
Score |
| 2024 |
Allard C, Miralpeix C, López-Gambero AJ, Cota D. mTORC1 in energy expenditure: consequences for obesity. Nature Reviews. Endocrinology. PMID 38225400 DOI: 10.1038/s41574-023-00934-0 |
0.424 |
|
| 2023 |
Sepúlveda C, Rodríguez JM, Monsalves-Álvarez M, Donoso-Barraza C, Pino-de la Fuente F, Matías I, Leste-Lasserre T, Zizzari P, Morselli E, Cota D, Llanos M, Troncoso R. The CB1 cannabinoid receptor regulates autophagy in the tibialis anterior skeletal muscle in mice. Biological Research. 56: 14. PMID 36964619 DOI: 10.1186/s40659-023-00426-5 |
0.333 |
|
| 2022 |
Lee TH, Cota D, Quarta C. Yin-Yang control of energy balance by lipids in the hypothalamus: The endocannabinoids vs bile acids case. Biochimie. PMID 35863558 DOI: 10.1016/j.biochi.2022.07.006 |
0.424 |
|
| 2021 |
Miralpeix C, Reguera AC, Fosch A, Zagmutt S, Casals N, Cota D, Rodríguez-Rodríguez R. Hypothalamic endocannabinoids in obesity: an old story with new challenges. Cellular and Molecular Life Sciences : Cmls. 78: 7469-7490. PMID 34718828 DOI: 10.1007/s00018-021-04002-6 |
0.402 |
|
| 2021 |
Sighinolfi G, Clark S, Blanc L, Cota D, Rhourri-Frih B. Mass spectrometry imaging of mice brain lipid profile changes over time under high fat diet. Scientific Reports. 11: 19664. PMID 34608169 DOI: 10.1038/s41598-021-97201-x |
0.323 |
|
| 2021 |
Marion C, Zizzari P, Denis RG, Hassouna R, Chebani Y, Leste-Lasserre T, Doat H, Le Pen G, Cota D, Noble F, Luquet S, Pantel J. The GhsrQ343X allele favors the storage of fat by acting on nutrient partitioning. The Journal of Endocrinology. PMID 34582357 DOI: 10.1530/JOE-20-0576 |
0.337 |
|
| 2021 |
Perino A, Velázquez-Villegas LA, Bresciani N, Sun Y, Huang Q, Fénelon VS, Castellanos-Jankiewicz A, Zizzari P, Bruschetta G, Jin S, Baleisyte A, Gioiello A, Pellicciari R, Ivanisevic J, Schneider BL, ... ... Cota D, et al. Central anorexigenic actions of bile acids are mediated by TGR5. Nature Metabolism. 3: 595-603. PMID 34031591 DOI: 10.1038/s42255-021-00398-4 |
0.341 |
|
| 2021 |
Castellanos-Jankiewicz A, Guzmán-Quevedo O, Fénelon VS, Zizzari P, Quarta C, Bellocchio L, Tailleux A, Charton J, Fernandois D, Henricsson M, Piveteau C, Simon V, Allard C, Quemener S, Guinot V, ... ... Cota D, et al. Hypothalamic bile acid-TGR5 signaling protects from obesity. Cell Metabolism. PMID 33887197 DOI: 10.1016/j.cmet.2021.04.009 |
0.406 |
|
| 2021 |
Quarta C, Claret M, Zeltser LM, Williams KW, Yeo GSH, Tschöp MH, Diano S, Brüning JC, Cota D. POMC neuronal heterogeneity in energy balance and beyond: an integrated view. Nature Metabolism. PMID 33633406 DOI: 10.1038/s42255-021-00345-3 |
0.316 |
|
| 2020 |
Zizzari P, He R, Falk S, Bellocchio L, Allard C, Clark S, Lesté-Lasserre T, Marsicano G, Clemmensen C, Perez-Tilve D, Finan B, Cota D, Quarta C. CB1 and GLP-1 Receptors Cross-Talk Provides New Therapies for Obesity. Diabetes. PMID 33144338 DOI: 10.2337/db20-0162 |
0.388 |
|
| 2020 |
Soty M, Vily-Petit J, Castellanos-Jankiewicz A, Guzman-Quevedo O, Raffin M, Clark S, Silva M, Gautier-Stein A, Cota D, Mithieux G. Calcitonin gene-related peptide-induced phosphorylation of STAT3 in arcuate neurons is a link in the metabolic benefits of portal glucose. Neuroendocrinology. PMID 32516785 DOI: 10.1159/000509230 |
0.358 |
|
| 2020 |
Tischmann L, Drummen M, Joris PJ, Gatta-Cherifi B, Raben A, Fogelholm M, Matias I, Cota D, Mensink RP, Westerterp-Plantenga MS, Adam TC. Effects of a High-Protein Diet on Cardiometabolic Health, Vascular Function, and Endocannabinoids-A PREVIEW Study. Nutrients. 12. PMID 32455987 DOI: 10.3390/Nu12051512 |
0.314 |
|
| 2020 |
Drummen M, Tischmann L, Gatta-Cherifi B, Cota D, Matias I, Raben A, Adam T, Westerterp-Plantenga M. Role of endocannabinoids in energy balance regulation in participants in the post-obese state - a PREVIEW study. The Journal of Clinical Endocrinology and Metabolism. PMID 32333763 DOI: 10.1210/Clinem/Dgaa193 |
0.436 |
|
| 2020 |
Quarta C, Cota D. Anti-obesity therapy with peripheral CB1 blockers: from promise to safe(?) practice. International Journal of Obesity (2005). PMID 32317751 DOI: 10.1038/S41366-020-0577-8 |
0.393 |
|
| 2019 |
Quarta C, Fioramonti X, Cota D. POMC Neurons Dysfunction in Diet-induced Metabolic Disease: Hallmark or Mechanism of Disease? Neuroscience. PMID 31689486 DOI: 10.1016/J.Neuroscience.2019.09.031 |
0.45 |
|
| 2019 |
Tischmann L, Drummen M, Gatta-Cherifi B, Raben A, Fogelholm M, Hartmann B, Holst JJ, Matias I, Cota D, Mensink RP, Joris PJ, Westerterp-Plantenga MS, Adam TC. Effects of a High-Protein/Moderate-Carbohydrate Diet on Appetite, Gut Peptides, and Endocannabinoids-A Preview Study. Nutrients. 11. PMID 31546629 DOI: 10.3390/Nu11102269 |
0.428 |
|
| 2019 |
Mazier W, Saucisse N, Simon V, Cannich A, Marsicano G, Massa F, Cota D. mTORC1 and CB1 receptor signaling regulate excitatory glutamatergic inputs onto the hypothalamic paraventricular nucleus in response to energy availability. Molecular Metabolism. PMID 31420305 DOI: 10.1016/J.Molmet.2019.08.005 |
0.453 |
|
| 2019 |
Bouyakdan K, Martin H, Liénard F, Budry L, Taib B, Rodaros D, Chrétien C, Biron É, Husson Z, Cota D, Pénicaud L, Fulton S, Fioramonti X, Alquier T. The gliotransmitter ACBP controls feeding and energy homeostasis via the melanocortin system. The Journal of Clinical Investigation. 130. PMID 30938715 DOI: 10.1172/Jci123454 |
0.502 |
|
| 2018 |
Hutch CR, Trakimas DR, Roelofs K, Pressler J, Sorrell J, Cota D, Obici S, Sandoval DA. Oea Signaling Pathways and the Metabolic Benefits of Vertical Sleeve Gastrectomy. Annals of Surgery. PMID 30702457 DOI: 10.1097/Sla.0000000000003093 |
0.392 |
|
| 2018 |
Haissaguerre M, Ferriere A, Clark S, Guzman-Quevedo O, Tabarin A, Cota D. NPV-BSK805, an Antineoplastic Jak2 Inhibitor Effective in Myeloproliferative Disorders, Causes Adiposity in Mice by Interfering With the Action of Leptin. Frontiers in Pharmacology. 9: 527. PMID 29867515 DOI: 10.3389/Fphar.2018.00527 |
0.485 |
|
| 2018 |
Haissaguerre M, Ferrière A, Simon V, Saucisse N, Dupuy N, André C, Clark S, Guzman-Quevedo O, Tabarin A, Cota D. mTORC1-dependent increase in oxidative metabolism in POMC neurons regulates food intake and action of leptin. Molecular Metabolism. PMID 29699927 DOI: 10.1016/J.Molmet.2018.04.002 |
0.414 |
|
| 2018 |
André C, Catania C, Remus-Borel J, Ladeveze E, Leste-Lasserre T, Mazier W, Binder E, Gonzales D, Clark S, Guzman-Quevedo O, Abrous DN, Layé S, Cota D. mTORC1 pathway disruption abrogates the effects of the ciliary neurotrophic factor on energy balance and hypothalamic neuroinflammation. Brain, Behavior, and Immunity. PMID 29548998 DOI: 10.1016/J.Bbi.2018.03.014 |
0.506 |
|
| 2017 |
Javary J, Allain-Courtois N, Saucisse N, Costet P, Heraud C, Benhamed F, Pierre R, Bure C, Pallares-Lupon N, Do Cruzeiro M, Postic C, Cota D, Dubus P, Rosenbaum J, Benhamouche-Trouillet S. Liver Reptin/RUVBL2 controls glucose and lipid metabolism with opposite actions on mTORC1 and mTORC2 signalling. Gut. PMID 29074727 DOI: 10.1136/Gutjnl-2017-314208 |
0.325 |
|
| 2017 |
Ruiz de Azua I, Mancini G, Srivastava RK, Rey AA, Cardinal P, Tedesco L, Zingaretti CM, Sassmann A, Quarta C, Schwitter C, Conrad A, Wettschureck N, Vemuri VK, Makriyannis A, Hartwig J, ... ... Cota D, et al. Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophages. The Journal of Clinical Investigation. PMID 29035280 DOI: 10.1172/Jci83626 |
0.511 |
|
| 2017 |
Cota D. The brain strikes back: Hypothalamic targets for peripheral CB1 receptor inverse agonism. Molecular Metabolism. 6: 1077-1078. PMID 29031708 DOI: 10.1016/J.Molmet.2017.07.003 |
0.304 |
|
| 2017 |
Quarta C, Clemmensen C, Zhu Z, Yang B, Joseph SS, Lutter D, Yi CX, Graf E, García-Cáceres C, Legutko B, Fischer K, Brommage R, Zizzari P, Franklin BS, Krueger M, ... ... Cota D, et al. Molecular Integration of Incretin and Glucocorticoid Action Reverses Immunometabolic Dysfunction and Obesity. Cell Metabolism. PMID 28943448 DOI: 10.1016/J.Cmet.2017.08.023 |
0.622 |
|
| 2017 |
Lau BK, Cota D, Cristino L, Borgland SL. Endocannabinoid modulation of homeostatic and non-homeostatic feeding circuits. Neuropharmacology. PMID 28579186 DOI: 10.1016/J.Neuropharm.2017.05.033 |
0.504 |
|
| 2017 |
Piazza PV, Cota D, Marsicano G. The CB1 Receptor as the Cornerstone of Exostasis. Neuron. 93: 1252-1274. PMID 28334603 DOI: 10.1016/J.Neuron.2017.02.002 |
0.38 |
|
| 2017 |
Simon V, Cota D. MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future. European Journal of Endocrinology. PMID 28246151 DOI: 10.1530/Eje-16-1044 |
0.506 |
|
| 2017 |
Khlaifia A, Matias I, Cota D, Tell F. Nutritional status dependent endocannabinoid signalling regulates the integration of rat visceral information. The Journal of Physiology. PMID 28233325 DOI: 10.1113/Jp273484 |
0.433 |
|
| 2016 |
André C, Guzman-Quevedo O, Rey C, Rémus-Borel J, Clark S, Castellanos-Jankiewicz A, Ladeveze E, Leste-Lasserre T, Nadjar A, Abrous DN, Laye S, Cota D. Inhibiting Microglia Expansion Prevents Diet-induced Hypothalamic and Peripheral Inflammation. Diabetes. PMID 27903745 DOI: 10.2337/Db16-0586 |
0.451 |
|
| 2016 |
Hebert-Chatelain E, Desprez T, Serrat R, Bellocchio L, Soria-Gomez E, Busquets-Garcia A, Zottola AC, Delamarre A, Cannich A, Vincent P, Varilh M, Robin LM, Terral G, García-Fernández MD, Colavita M, ... ... Cota D, et al. A cannabinoid link between mitochondria and memory. Nature. PMID 27828947 DOI: 10.1016/J.Bbabio.2016.04.251 |
0.311 |
|
| 2015 |
Haissaguerre M, Cota D. [Role of the mTOR pathway in the central regulation of energy balance]. Biologie Aujourd'Hui. 209: 295-307. PMID 27021048 DOI: 10.1051/Jbio/2016009 |
0.513 |
|
| 2015 |
Bermudez-Silva FJ, Romero-Zerbo SY, Haissaguerre M, Ruz-Maldonado I, Lhamyani S, El Bekay R, Tabarin A, Marsicano G, Cota D. Cannabinoid CB1 receptors and mTORC1 signalling pathway interact to modulate glucose homeostasis. Disease Models & Mechanisms. PMID 26563389 DOI: 10.1242/Dmm.020750 |
0.425 |
|
| 2015 |
Mazier W, Saucisse N, Gatta-Cherifi B, Cota D. The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease. Trends in Endocrinology and Metabolism: Tem. 26: 524-37. PMID 26412154 DOI: 10.1016/J.Tem.2015.07.007 |
0.49 |
|
| 2015 |
Gatta-Cherifi B, Cota D. Endocannabinoids and Metabolic Disorders. Handbook of Experimental Pharmacology. 231: 367-91. PMID 26408168 DOI: 10.1007/978-3-319-20825-1_13 |
0.437 |
|
| 2015 |
Gatta-Cherifi B, Cota D. New insights on the role of the endocannabinoid system in the regulation of energy balance. International Journal of Obesity (2005). PMID 26374449 DOI: 10.1038/Ijo.2015.179 |
0.513 |
|
| 2015 |
Cardinal P, Bellocchio L, Guzmán-Quevedo O, André C, Clark S, Elie M, Leste-Lasserre T, Gonzales D, Cannich A, Marsicano G, Cota D. Cannabinoid type 1 (CB1) receptors on Sim1-expressing neurons regulate energy expenditure in male mice. Endocrinology. 156: 411-8. PMID 25456065 DOI: 10.1210/En.2014-1437 |
0.499 |
|
| 2015 |
Lu B, Diz-Chaves Y, Markovic D, Contarino A, Penicaud L, Fanelli F, Clark S, Lehnert H, Cota D, Grammatopoulos DK, Tabarin A. The corticotrophin-releasing factor/urocortin system regulates white fat browning in mice through paracrine mechanisms. International Journal of Obesity (2005). 39: 408-17. PMID 25189177 DOI: 10.1038/Ijo.2014.164 |
0.303 |
|
| 2014 |
Cardinal P, André C, Quarta C, Bellocchio L, Clark S, Elie M, Leste-Lasserre T, Maitre M, Gonzales D, Cannich A, Pagotto U, Marsicano G, Cota D. CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin. Molecular Metabolism. 3: 705-16. PMID 25352999 DOI: 10.1016/J.Molmet.2014.07.004 |
0.464 |
|
| 2014 |
Haissaguerre M, Saucisse N, Cota D. Influence of mTOR in energy and metabolic homeostasis. Molecular and Cellular Endocrinology. 397: 67-77. PMID 25109278 DOI: 10.1016/J.Mce.2014.07.015 |
0.484 |
|
| 2014 |
Cota D. mTORC2, the "other" mTOR, is a new player in energy balance regulation. Molecular Metabolism. 3: 349-50. PMID 24944894 DOI: 10.1016/J.Molmet.2014.04.002 |
0.462 |
|
| 2014 |
Soria-Gómez E, Massa F, Bellocchio L, Rueda-Orozco PE, Ciofi P, Cota D, Oliet SH, Prospéro-GarcÃa O, Marsicano G. Cannabinoid type-1 receptors in the paraventricular nucleus of the hypothalamus inhibit stimulated food intake. Neuroscience. 263: 46-53. PMID 24434770 DOI: 10.1016/J.Neuroscience.2014.01.005 |
0.465 |
|
| 2014 |
Binder E, Bermúdez-Silva FJ, Elie M, Leste-Lasserre T, Belluomo I, Clark S, Duchampt A, Mithieux G, Cota D. Leucine supplementation modulates fuel substrates utilization and glucose metabolism in previously obese mice. Obesity (Silver Spring, Md.). 22: 713-20. PMID 23894080 DOI: 10.1002/Oby.20578 |
0.474 |
|
| 2013 |
Bosier B, Bellocchio L, Metna-Laurent M, Soria-Gomez E, Matias I, Hebert-Chatelain E, Cannich A, Maitre M, Leste-Lasserre T, Cardinal P, Mendizabal-Zubiaga J, Canduela MJ, Reguero L, Hermans E, Grandes P, ... Cota D, et al. Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes. Molecular Metabolism. 2: 393-404. PMID 24327955 DOI: 10.1016/J.Molmet.2013.08.001 |
0.437 |
|
| 2013 |
Binder E, Bermúdez-Silva FJ, André C, Elie M, Romero-Zerbo SY, Leste-Lasserre T, Belluomo I, Duchampt A, Clark S, Aubert A, Mezzullo M, Fanelli F, Pagotto U, Layé S, Mithieux G, ... Cota D, et al. Leucine supplementation protects from insulin resistance by regulating adiposity levels. Plos One. 8: e74705. PMID 24086364 DOI: 10.1371/Journal.Pone.0074705 |
0.463 |
|
| 2013 |
Bellocchio L, Soria-Gómez E, Quarta C, Metna-Laurent M, Cardinal P, Binder E, Cannich A, Delamarre A, Häring M, MartÃn-Fontecha M, Vega D, Leste-Lasserre T, Bartsch D, Monory K, Lutz B, ... ... Cota D, et al. Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CBâ‚ receptor blockade. Proceedings of the National Academy of Sciences of the United States of America. 110: 4786-91. PMID 23487769 DOI: 10.1073/Pnas.1218573110 |
0.406 |
|
| 2012 |
André C, Cota D. Coupling nutrient sensing to metabolic homoeostasis: the role of the mammalian target of rapamycin complex 1 pathway. The Proceedings of the Nutrition Society. 71: 502-10. PMID 22877732 DOI: 10.1017/S0029665112000754 |
0.386 |
|
| 2012 |
Matias I, Gatta-Cherifi B, Tabarin A, Clark S, Leste-Lasserre T, Marsicano G, Piazza PV, Cota D. Endocannabinoids measurement in human saliva as potential biomarker of obesity. Plos One. 7: e42399. PMID 22860123 DOI: 10.1371/Journal.Pone.0042399 |
0.428 |
|
| 2012 |
Cardinal P, Bellocchio L, Clark S, Cannich A, Klugmann M, Lutz B, Marsicano G, Cota D. Hypothalamic CB1 cannabinoid receptors regulate energy balance in mice. Endocrinology. 153: 4136-43. PMID 22778221 DOI: 10.1210/En.2012-1405 |
0.51 |
|
| 2012 |
Gatta-Cherifi B, Matias I, Vallée M, Tabarin A, Marsicano G, Piazza PV, Cota D. Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity. International Journal of Obesity (2005). 36: 880-5. PMID 21844878 DOI: 10.1038/Ijo.2011.165 |
0.452 |
|
| 2012 |
Bermudez-Silva FJ, Cardinal P, Cota D. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance. Journal of Psychopharmacology (Oxford, England). 26: 114-24. PMID 21824982 DOI: 10.1177/0269881111408458 |
0.552 |
|
| 2012 |
Matias I, Gatta-Cherifi B, Cota D. Obesity and the Endocannabinoid System: Circulating Endocannabinoids and Obesity Current Obesity Reports. 1: 229-235. DOI: 10.1007/S13679-012-0027-6 |
0.447 |
|
| 2011 |
Bajzer M, Olivieri M, Haas MK, Pfluger PT, Magrisso IJ, Foster MT, Tschöp MH, Krawczewski-Carhuatanta KA, Cota D, Obici S. Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice. Diabetologia. 54: 3121-31. PMID 21987346 DOI: 10.1007/S00125-011-2302-6 |
0.64 |
|
| 2011 |
Cota D, Marsicano G. New fat and new neurons: endocannabinoids control neurogenesis in obesity (Commentary on Rivera et al.). The European Journal of Neuroscience. 33: 1575-6. PMID 21535244 DOI: 10.1111/J.1460-9568.2011.07684.X |
0.378 |
|
| 2011 |
Catania C, Binder E, Cota D. mTORC1 signaling in energy balance and metabolic disease. International Journal of Obesity (2005). 35: 751-61. PMID 20877289 DOI: 10.1038/Ijo.2010.208 |
0.52 |
|
| 2011 |
Gatta-Cherifi B, Matias I, Vallee M, Tabarin A, Marsicano G, Piazza PV, Cota D. Synergistic post-prandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity Appetite. 57. DOI: 10.1016/J.Appet.2011.05.174 |
0.353 |
|
| 2010 |
Quarta C, Bellocchio L, Mancini G, Mazza R, Cervino C, Braulke LJ, Fekete C, Latorre R, Nanni C, Bucci M, Clemens LE, Heldmaier G, Watanabe M, Leste-Lassere T, Maitre M, ... ... Cota D, et al. CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. Cell Metabolism. 11: 273-85. PMID 20374960 DOI: 10.1016/J.Cmet.2010.02.015 |
0.53 |
|
| 2010 |
Bellocchio L, Lafenêtre P, Cannich A, Cota D, Puente N, Grandes P, Chaouloff F, Piazza PV, Marsicano G. Bimodal control of stimulated food intake by the endocannabinoid system. Nature Neuroscience. 13: 281-3. PMID 20139974 DOI: 10.1038/Nn.2494 |
0.412 |
|
| 2009 |
Villanueva EC, Münzberg H, Cota D, Leshan RL, Kopp K, Ishida-Takahashi R, Jones JC, Fingar DC, Seeley RJ, Myers MG. Complex regulation of mammalian target of rapamycin complex 1 in the basomedial hypothalamus by leptin and nutritional status. Endocrinology. 150: 4541-51. PMID 19628573 DOI: 10.1210/En.2009-0642 |
0.593 |
|
| 2009 |
Cota D, Sandoval DA, Olivieri M, Prodi E, D'Alessio DA, Woods SC, Seeley RJ, Obici S. Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism. Obesity (Silver Spring, Md.). 17: 1641-5. PMID 19325539 DOI: 10.1038/Oby.2009.84 |
0.673 |
|
| 2009 |
Cota D. Mammalian target of rapamycin complex 1 (mTORC1) signaling in energy balance and obesity. Physiology & Behavior. 97: 520-4. PMID 19296907 DOI: 10.1016/J.Physbeh.2009.03.006 |
0.523 |
|
| 2008 |
Proulx K, Cota D, Woods SC, Seeley RJ. Fatty acid synthase inhibitors modulate energy balance via mammalian target of rapamycin complex 1 signaling in the central nervous system. Diabetes. 57: 3231-8. PMID 18776140 DOI: 10.2337/Db07-1690 |
0.656 |
|
| 2008 |
Cota D, Matter EK, Woods SC, Seeley RJ. The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 7202-8. PMID 18614690 DOI: 10.1523/Jneurosci.1389-08.2008 |
0.689 |
|
| 2008 |
Woods SC, Seeley RJ, Cota D. Regulation of food intake through hypothalamic signaling networks involving mTOR. Annual Review of Nutrition. 28: 295-311. PMID 18429698 DOI: 10.1146/Annurev.Nutr.28.061807.155505 |
0.68 |
|
| 2008 |
Cota D. Role of the endocannabinoid system in energy balance regulation and obesity. Frontiers of Hormone Research. 36: 135-45. PMID 18230900 DOI: 10.1159/000115362 |
0.517 |
|
| 2008 |
Sandoval D, Cota D, Seeley RJ. The integrative role of CNS fuel-sensing mechanisms in energy balance and glucose regulation. Annual Review of Physiology. 70: 513-35. PMID 17988209 DOI: 10.1146/Annurev.Physiol.70.120806.095256 |
0.613 |
|
| 2008 |
Cota D, Matter E, Woods S, Seeley R. The role of hypothalamic mTORC1 signaling in diet-induced obesity Appetite. 51: 360. DOI: 10.1016/J.Appet.2008.04.061 |
0.657 |
|
| 2007 |
Cota D. CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health. Diabetes/Metabolism Research and Reviews. 23: 507-17. PMID 17683024 DOI: 10.1002/Dmrr.764 |
0.507 |
|
| 2007 |
Cota D, Proulx K, Seeley RJ. The role of CNS fuel sensing in energy and glucose regulation. Gastroenterology. 132: 2158-68. PMID 17498509 DOI: 10.1053/J.Gastro.2007.03.049 |
0.612 |
|
| 2007 |
Cota D, Steiner MA, Marsicano G, Cervino C, Herman JP, Grübler Y, Stalla J, Pasquali R, Lutz B, Stalla GK, Pagotto U. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology. 148: 1574-81. PMID 17194743 DOI: 10.1210/En.2005-1649 |
0.355 |
|
| 2006 |
Cota D, Barrera JG, Seeley RJ. Leptin in energy balance and reward: two faces of the same coin? Neuron. 51: 678-80. PMID 16982412 DOI: 10.1016/J.Neuron.2006.09.009 |
0.534 |
|
| 2006 |
Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, Woods SC, Seeley RJ. Hypothalamic mTOR signaling regulates food intake. Science (New York, N.Y.). 312: 927-30. PMID 16690869 DOI: 10.1126/Science.1124147 |
0.677 |
|
| 2006 |
Cota D, Tschöp MH, Horvath TL, Levine AS. Cannabinoids, opioids and eating behavior: the molecular face of hedonism? Brain Research Reviews. 51: 85-107. PMID 16364446 DOI: 10.1016/J.Brainresrev.2005.10.004 |
0.452 |
|
| 2006 |
Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocrine Reviews. 27: 73-100. PMID 16306385 DOI: 10.1210/Er.2005-0009 |
0.453 |
|
| 2006 |
Tangalos EG, Cota D, Fujioka K. Complex Cardiometabolic Risk Factors: Impact, Assessment, and Emerging Therapies Journal of the American Medical Directors Association. 7: 1-10. DOI: 10.1016/J.Jamda.2006.06.003 |
0.457 |
|
| 2006 |
Cota D, Proulx K, Woods SC, Seeley RJ. Response [5] Science. 313: 1236+1238. |
0.312 |
|
| 2005 |
Proulx K, Cota D, Castañeda TR, Tschöp MH, D'Alessio DA, Tso P, Woods SC, Seeley RJ. Mechanisms of oleoylethanolamide-induced changes in feeding behavior and motor activity. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 289: R729-37. PMID 15879057 DOI: 10.1152/Ajpregu.00029.2005 |
0.618 |
|
| 2005 |
Cota D, Woods SC. The role of the endocannabinoid system in the regulation of energy homeostasis Current Opinion in Endocrinology and Diabetes. 12: 338-351. DOI: 10.1097/01.Med.0000178715.87999.69 |
0.569 |
|
| 2003 |
Cota D, Genghini S, Pasquali R, Pagotto U. Antagonizing the cannabinoid receptor type 1: a dual way to fight obesity. Journal of Endocrinological Investigation. 26: 1041-4. PMID 14759080 DOI: 10.1007/Bf03348205 |
0.488 |
|
| 2003 |
Cota D, Marsicano G, Tschöp M, Grübler Y, Flachskamm C, Schubert M, Auer D, Yassouridis A, Thöne-Reineke C, Ortmann S, Tomassoni F, Cervino C, Nisoli E, Linthorst AC, Pasquali R, et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. The Journal of Clinical Investigation. 112: 423-31. PMID 12897210 DOI: 10.1172/Jci17725 |
0.488 |
|
| 2003 |
Cota D, Marsicano G, Lutz B, Vicennati V, Stalla GK, Pasquali R, Pagotto U. Endogenous cannabinoid system as a modulator of food intake. International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association For the Study of Obesity. 27: 289-301. PMID 12629555 DOI: 10.1038/Sj.Ijo.0802250 |
0.465 |
|
| 2003 |
Marsicano G, Cota D, Stalla GK, Pasquali R, Pagotto U, Lutz B. Cannabinoids in energy balance and prospectives in the therapy of obesity Current Medicinal Chemistry - Central Nervous System Agents. 3: 81-87. DOI: 10.2174/1568015033477839 |
0.404 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2022 |
López-Gambero AJ, Pacheco-Sánchez B, Rosell-Valle C, Medina-Vera D, Navarro JA, Fernández-Arjona MDM, de Ceglia M, Sanjuan C, Simon V, Cota D, Rivera P, Rodríguez de Fonseca F, Suárez J. Dietary administration of D-chiro-inositol attenuates sex-specific metabolic imbalances in the 5xFAD mouse model of Alzheimer's disease. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 150: 112994. PMID 35483188 DOI: 10.1016/j.biopha.2022.112994 |
0.293 |
|
| 2023 |
Allard C, Cota D, Quarta C. Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges. Drugs. PMID 38127286 DOI: 10.1007/s40265-023-01982-6 |
0.287 |
|
| 2022 |
Fénelon VS, Cota D. [Hypothalamic bile acid-TGR5 signaling: A therapeutic target in the fight against obesity?] Medecine Sciences : M/S. 38: 413-415. PMID 35608459 DOI: 10.1051/medsci/2022052 |
0.286 |
|
| 2022 |
Pagano Zottola AC, Severi I, Cannich A, Ciofi P, Cota D, Marsicano G, Giordano A, Bellocchio L. Expression of Functional Cannabinoid Type-1 (CB) Receptor in Mitochondria of White Adipocytes. Cells. 11. PMID 36010658 DOI: 10.3390/cells11162582 |
0.285 |
|
| 2008 |
Cota D. The role of the endocannabinoid system in the regulation of hypothalamic-pituitary-adrenal axis activity. Journal of Neuroendocrinology. 20: 35-8. PMID 18426497 DOI: 10.1111/j.1365-2826.2008.01673.x |
0.28 |
|
| 2020 |
Di Miceli M, Husson Z, Ruel P, Layé S, Cota D, Fioramonti X, Bosch-Bouju C, Gronier B. Hierarchical Clustering of Neuronal Populations in the Rat Ventral Tegmental Area Based on Extracellular Electrophysiological Properties. Frontiers in Neural Circuits. 14: 51. PMID 32903825 DOI: 10.3389/Fncir.2020.00051 |
0.253 |
|
| 2021 |
Saucisse N, Mazier W, Simon V, Binder E, Catania C, Bellocchio L, Romanov RA, Léon S, Matias I, Zizzari P, Quarta C, Cannich A, Meece K, Gonzales D, Clark S, ... ... Cota D, et al. Functional heterogeneity of POMC neurons relies on mTORC1 signaling. Cell Reports. 37: 109800. PMID 34644574 DOI: 10.1016/j.celrep.2021.109800 |
0.253 |
|
| 2014 |
Aouizerate B, Gouzien C, Doumy O, Philip P, Semal C, Demany L, Piazza PV, Cota D. Toward a new computer-based and easy-to-use tool for the objective measurement of motivational states in humans: a pilot study Bmc Psychology. 2. DOI: 10.1186/S40359-014-0023-6 |
0.251 |
|
| 2015 |
Haissaguerre M, Ferrière A, Clark S, Guzman-Quevedo O, Dupuy N, Tabarin A, Cota D. Étude de l’interaction entre les espèces réactives dérivées de l’oxygène (ROS) et la voie mTORC1 dans la régulation hypothalamique de la balance énergétique Annales D'Endocrinologie. 76: 334. DOI: 10.1016/J.Ando.2015.07.120 |
0.25 |
|
| 2020 |
Zhao Z, Soria-Gómez E, Varilh M, Covelo A, Julio-Kalajzić F, Cannich A, Castiglione A, Vanhoutte L, Duveau A, Zizzari P, Beyeler A, Cota D, Bellocchio L, Busquets-Garcia A, Marsicano G. A Novel Cortical Mechanism for Top-Down Control of Water Intake. Current Biology : Cb. PMID 33035479 DOI: 10.1016/j.cub.2020.09.011 |
0.245 |
|
| 2022 |
Allard C, Zizzari P, Quarta C, Cota D. Food intake and body weight in rodent studies: the devil is in the details. Nature Metabolism. 4: 1424-1426. PMID 36253619 DOI: 10.1038/s42255-022-00658-x |
0.24 |
|
| 2018 |
Verdier F, Ferrière A, Haïssaguerre M, Teynié J, Perez P, Sitta R, Cota D, Matias I, Gatta-Cherifi B, Tabarin A. Étude des interactions entre le système endocannabinoïde et la pathologie de l’axe corticotrope chez l’Homme Annales D'Endocrinologie. 79: 286. DOI: 10.1016/J.Ando.2018.06.271 |
0.234 |
|
| 2018 |
Blaszczyk L, Maître M, Lesté-Lasserre T, Clark S, Cota D, Oliet SHR, Fénelon VS. Sequential alteration of microglia and astrocytes in the rat thalamus following spinal nerve ligation. Journal of Neuroinflammation. 15: 349. PMID 30572902 DOI: 10.1186/S12974-018-1378-Z |
0.229 |
|
| 2016 |
Cota D. Régulation centrale de l’homéostasie énergétique par les endocannabinoïdes Annales D'Endocrinologie. 77: 240. DOI: 10.1016/J.Ando.2016.07.018 |
0.219 |
|
| 2018 |
Lavielle A, Etchamendy N, Santos A, Pupier E, Cota D, Webb S, Tabarin A. Séquelles cognitives de la maladie de Cushing : étude MEMOCUSH Annales D Endocrinologie. 79: 246. DOI: 10.1016/J.Ando.2018.06.144 |
0.204 |
|
| 2021 |
De Meij J, Alfanek Z, Morel L, Decoeur F, Leyrolle Q, Picard K, Carrier M, Aubert A, Séré A, Lucas C, Laforest G, Helbling JC, Tremblay ME, Cota D, Moisan MP, et al. Microglial Cannabinoid Type 1 Receptor Regulates Brain Inflammation in a Sex-Specific Manner. Cannabis and Cannabinoid Research. PMID 34591647 DOI: 10.1089/can.2020.0170 |
0.2 |
|
| 2017 |
Mazier W, Cota D. Islet Endothelial Cell: Friend and Foe. Endocrinology. 158: 226-228. PMID 28430925 DOI: 10.1210/En.2016-1925 |
0.191 |
|
| 2022 |
Di Franco N, Drutel G, Roullot-Lacarrière V, Julio-Kalajzic F, Lalanne V, Grel A, Leste-Lasserre T, Matias I, Cannich A, Gonzales D, Simon V, Cota D, Marsicano G, Piazza PV, Vallée M, et al. Differential expression of the neuronal CB1 cannabinoid receptor in the hippocampus of male Ts65Dn Down syndrome mouse model. Molecular and Cellular Neurosciences. 103705. PMID 35158060 DOI: 10.1016/j.mcn.2022.103705 |
0.189 |
|
| 2022 |
Martin H, Bullich S, Martinat M, Chataigner M, Di Miceli M, Simon V, Clark S, Butler J, Schell M, Chopra S, Chaouloff F, Kleinridders A, Cota D, De Deurwaerdere P, Pénicaud L, et al. Insulin modulates emotional behavior through a serotonin-dependent mechanism. Molecular Psychiatry. PMID 36207585 DOI: 10.1038/s41380-022-01812-3 |
0.184 |
|
| 2021 |
Koehl M, Ladevèze E, Catania C, Cota D, Abrous DN. Inhibition of mTOR signaling by genetic removal of p70 S6 kinase 1 increases anxiety-like behavior in mice. Translational Psychiatry. 11: 165. PMID 33723223 DOI: 10.1038/s41398-020-01187-5 |
0.163 |
|
| 2003 |
Cota D, Marsicano G, Grübler Y, Stalla J, Pasquali R, Lutz B, Pagotto U, Stalla G. Cannabinoid receptor type 1 (CB1) affects hypothalamic-pituitary-adrenal (HPA) axis activity at cerebral and pituitary level Experimental and Clinical Endocrinology & Diabetes. 111. DOI: 10.1055/s-2003-817562 |
0.159 |
|
| 2021 |
Enaud R, Cambos S, Viaud E, Guichoux E, Chancerel E, Marighetto A, Etchamendy N, Clark S, Mohammedi K, Cota D, Delhaes L, Gatta-Cherifi B. Gut Microbiota and Mycobiota Evolution Is Linked to Memory Improvement after Bariatric Surgery in Obese Patients: A Pilot Study. Nutrients. 13. PMID 34836316 DOI: 10.3390/nu13114061 |
0.158 |
|
| 2000 |
Cota D, Ceroni L, Pasquali R. [Steroid therapy and adrenal function]. Recenti Progressi in Medicina. 91: 594-600. PMID 11125954 |
0.154 |
|
| 2024 |
Vily-Petit J, Soty-Roca M, Silva M, Micoud M, Evrard F, Bron C, Raffin M, Beiroa D, Nogueiras R, Roussel D, Gautier-Stein A, Rajas F, Cota D, Gilles M. Antiobesity effects of intestinal gluconeogenesis are mediated by the brown adipose tissue sympathetic nervous system. Obesity (Silver Spring, Md.). PMID 38311801 DOI: 10.1002/oby.23985 |
0.12 |
|
| 2000 |
Ceroni L, Cota D, Pasquali R. [Pseudo-Cushing syndrome. Physiopathologic aspects and differential diagnosis]. Minerva Endocrinologica. 25: 47-54. PMID 11189791 |
0.101 |
|
| 2021 |
Masachs N, Charrier V, Farrugia F, Lemaire V, Blin N, Mazier W, Tronel S, Montaron MF, Ge S, Marsicano G, Cota D, Deroche-Gamonet V, Herry C, Abrous DN. The temporal origin of dentate granule neurons dictates their role in spatial memory. Molecular Psychiatry. PMID 34526669 DOI: 10.1038/s41380-021-01276-x |
0.096 |
|
| 2001 |
Cota D, Vicennati V, Ceroni L, Morselli-Labate AM, Pasquali R. Relationship between socio-economic and cultural status, psychological factors and body fat distribution in middle-aged women living in Northern Italy. Eating and Weight Disorders : Ewd. 6: 205-13. PMID 11808816 |
0.088 |
|
| 2023 |
Haney M, Vallée M, Fabre S, Collins Reed S, Zanese M, Campistron G, Arout CA, Foltin RW, Cooper ZD, Kearney-Ramos T, Metna M, Justinova Z, Schindler C, Hebert-Chatelain E, Bellocchio L, ... ... Cota D, et al. Signaling-specific inhibition of the CB receptor for cannabis use disorder: phase 1 and phase 2a randomized trials. Nature Medicine. PMID 37291212 DOI: 10.1038/s41591-023-02381-w |
0.083 |
|
| 2021 |
Lods M, Pacary E, Mazier W, Farrugia F, Mortessagne P, Masachs N, Charrier V, Massa F, Cota D, Ferreira G, Abrous DN, Tronel S. Adult-born neurons immature during learning are necessary for remote memory reconsolidation in rats. Nature Communications. 12: 1778. PMID 33741954 DOI: 10.1038/s41467-021-22069-4 |
0.074 |
|
| 2022 |
Lods M, Mortessagne P, Pacary E, Terral G, Farrugia F, Mazier W, Masachs N, Charrier V, Cota D, Ferreira G, Abrous DN, Tronel S. Chemogenetic stimulation of adult neurogenesis, and not neonatal neurogenesis, is sufficient to improve long-term memory accuracy. Progress in Neurobiology. 219: 102364. PMID 36244613 DOI: 10.1016/j.pneurobio.2022.102364 |
0.066 |
|
| 2013 |
Gatta Cherifi B, Maury E, Belluomo I, Isabelle M, Matias I, Tabarin A, Cota D, Rigalleau V. P2101 Effet d’un régime hypoglucidique sur le métabolisme et les concentrations plasmatiques des endocannabinoïdes chez des patients diabétiques de type 2 Diabetes & Metabolism. 39: A92. DOI: 10.1016/S1262-3636(13)72011-1 |
0.045 |
|
| 2005 |
de León ME, Martínez JL, Cota DL, Vázquez SH, Rafael P. Decadal variability in growth of the Caribbean spiny lobster Panulirus argus (Decapoda: Paniluridae) in Cuban waters. Revista De Biología Tropical. 53: 475-86. PMID 17354457 |
0.034 |
|
| 2012 |
Gatta-Cherifi B, Matias I, Tabarin A, Clark S, Lestte-Lasserre T, Marsicano G, Piazza P, Cota D. Un nouveau biomarqueur de l’obésité humaine : les endocannabinoïdes salivaires Annales D'Endocrinologie. 73: 424. DOI: 10.1016/J.Ando.2012.07.733 |
0.03 |
|
| 2022 |
Pupier E, Santos A, Etchamendy N, Lavielle A, Ferriere A, Marighetto A, Resmini E, Cota D, Webb SM, Tabarin A. Impaired quality of life, but not cognition, is linked to a history of chronic hypercortisolism in patients with Cushing's disease in remission. Frontiers in Endocrinology. 13: 934347. PMID 36004342 DOI: 10.3389/fendo.2022.934347 |
0.03 |
|
| Hide low-probability matches. |